170
Views
12
CrossRef citations to date
0
Altmetric
Drug Evaluations

Apaziquone as an intravesical therapeutic agent for urothelial non-muscle-invasive bladder cancer

, MD & , MD
Pages 251-260 | Published online: 21 Dec 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

R. M. Phillips, H. R. Hendriks, J. B. Sweeney, G. Reddy & G. J. Peters. (2017) Efficacy, pharmacokinetic and pharmacodynamic evaluation of apaziquone in the treatment of non-muscle invasive bladder cancer. Expert Opinion on Drug Metabolism & Toxicology 13:7, pages 783-791.
Read now
Anna V van Lingen, Tom JH Arends & J Alfred Witjes. (2013) Expert review: an update in current and developing intravesical therapies for non-muscle-invasive bladder cancer. Expert Review of Anticancer Therapy 13:11, pages 1257-1268.
Read now
Willem Oosterlinck & Karel Decaestecker. (2012) Current strategies in the treatment of non-muscle-invasive bladder cancer. Expert Review of Anticancer Therapy 12:8, pages 1097-1106.
Read now

Articles from other publishers (9)

Nora Astrain-Redin, Carmen Sanmartin, Arun K. Sharma & Daniel Plano. (2023) From Natural Sources to Synthetic Derivatives: The Allyl Motif as a Powerful Tool for Fragment-Based Design in Cancer Treatment. Journal of Medicinal Chemistry 66:6, pages 3703-3731.
Crossref
Adamshafi Shaik, Allaka Tejeswara Rao, S.V.M. Mohan Rao & Pilli V.V.N. Kishore. (2021) Synthesis of Biologically Active Novel Indole Fused Heterocyclic Derivatives: Molecular Modeling Studies. Asian Journal of Chemistry 33:7, pages 1677-1684.
Crossref
Sayan Pramanik, Suvendu Maity, Prasanta Ghosh & Chhanda Mukhopadhyay. (2019) Acid-promoted multicomponent allylic amidation towards 7-acetamido tetrahydroindole derivatives. Tetrahedron Letters 60:5, pages 435-438.
Crossref
Shengtao Xu, Hong Yao, Lingling Pei, Mei Hu, Dahong Li, Yangyi Qiu, Guangyu Wang, Liang Wu, Hequan Yao, Zheying Zhu & Jinyi Xu. (2017) Design, synthesis, and biological evaluation of NAD(P)H: Quinone oxidoreductase (NQO1)-targeted oridonin prodrugs possessing indolequinone moiety for hypoxia-selective activation. European Journal of Medicinal Chemistry 132, pages 310-321.
Crossref
Monikaben Padariya & Umesh Kalathiya. (2016) Structure-based design and evaluation of novel N-phenyl-1H-indol-2-amine derivatives for fat mass and obesity-associated (FTO) protein inhibition. Computational Biology and Chemistry 64, pages 414-425.
Crossref
Gunjan Srivastava, Raj Thani Somasundaram, Paul G. Walfish & Ranju Ralhan. (2015) Anticancer Activity of Apaziquone in Oral Cancer Cells and Xenograft Model: Implications for Oral Cancer Therapy. PLOS ONE 10:7, pages e0133735.
Crossref
Nagendra Kaushik, Neha Kaushik, Pankaj Attri, Naresh Kumar, Chung Kim, Akhilesh Verma & Eun Choi. (2013) Biomedical Importance of Indoles. Molecules 18:6, pages 6620-6662.
Crossref
David C. Johnson, Raj S. Pruthi & Michael E. Woods. (2013) Perioperative Chemotherapy. Urologic Clinics of North America 40:2, pages 183-195.
Crossref
Callum Logan, Matthew Brown & Dickon Hayne. (2012) Intravesical therapies for bladder cancer - indications and limitations. BJU International 110, pages 12-21.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.